• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.64% Nasdaq Down 0.55%

    XOMA Corporation (XOMA)

    -NasdaqGM
    3.52 Down 0.06(1.68%) May 29, 4:00PM EDT
    |After Hours : 3.52 0.00 (0.00%) May 29, 4:24PM EDT
    Add to Portfolio
    Prev Close:3.58
    Open:3.60
    Bid:3.56 x 200
    Ask:3.60 x 100
    1y Target Est:8.57
    Beta:3.62
    Earnings Date:Aug 5 - Aug 10 (Est.)
    Day's Range:3.51 - 3.70
    52wk Range:2.92 - 5.95
    Volume:2,029,922
    Avg Vol (3m):2,392,400
    Market Cap:414.71M
    P/E (ttm):N/A
    EPS (ttm):-0.69
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    XOMADown 1.68%414.71M
    NVSDown 1.46%248.64B
    REGNUp 0.09%52.94B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):23.29
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.63
    Quarterly EPS Est (Jun-15) :-0.18
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-0.30

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. The company’s lead product candidate includes gevokizumab, a proprietary humanized allosteric-modulating monoclonal antibo... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback